3908:HKEXChina International Capital Corp. Ltd. Class H Analysis
Data as of 2026-03-14 - not real-time
¥406.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Collabos Corporation is trading above its short‑term and medium‑term moving averages, indicating a prevailing bullish momentum despite a recent bearish MACD crossover and a dip in trading volume. The RSI sits in a comfortable middle range, suggesting the stock is not yet overbought, while the beta remains low, pointing to limited market‑wide volatility even as the 30‑day price swings are relatively high.
Fundamentally, the valuation appears attractive with a price‑to‑earnings multiple well below the industry average and a dividend yield that outperforms many peers. The balance sheet is solid, featuring ample cash and modest debt, supporting the sustainability of the dividend, yet revenue growth is negative and cash flow generation is weak, which tempers enthusiasm for aggressive price appreciation.
Fundamentally, the valuation appears attractive with a price‑to‑earnings multiple well below the industry average and a dividend yield that outperforms many peers. The balance sheet is solid, featuring ample cash and modest debt, supporting the sustainability of the dividend, yet revenue growth is negative and cash flow generation is weak, which tempers enthusiasm for aggressive price appreciation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Mixed technical signals with bearish MACD and falling volume
- High short‑term price volatility
- Low systematic risk reflected by a modest beta
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to sector peers
- Attractive dividend yield supported by strong cash position
- Low beta suggesting defensive characteristics
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Revenue contraction and limited cash flow generation
- Sustainable dividend providing income stability
- Stable balance sheet with low leverage
Key Metrics & Analysis
Financial Health
Revenue Growth-10.30%
Profit Margin6.76%
P/E Ratio13.8
ROE9.26%
ROA3.53%
Debt/Equity15.09
P/B Ratio1.4
Industry P/E33.7
Technical Analysis
TrendBullish
RSI59.4
Support¥378.00
Resistance¥417.00
MA 20¥397.10
MA 50¥357.74
MA 200¥343.92
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
GradeUndervalued
TypeValue
Dividend Yield2.96%
Risk Assessment
Beta0.45
Volatility35.42%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.